Fig. 2From: Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern MexicoCumulative incidence of Plasmodium vivax recurrences during the 12-month follow-up in groups of patients treated under supervision with combined CQ–PQ for 14 days (T14) and intermittent single doses (ISD). The CI at 95 % is shownBack to article page